Literature DB >> 17616350

High prevalence of the metabolic syndrome among Northern Jordanians.

Yousef Khader1, Anwar Bateiha, Mohammed El-Khateeb, Abeer Al-Shaikh, Kamel Ajlouni.   

Abstract

BACKGROUND: The prevalence of the metabolic syndrome is rapidly increasing with a considerable ethnic variation within and across populations. This study was conducted to estimate the prevalence of the metabolic syndrome and its individual components using Adult Treatment Panel III (ATP III) criteria among Northern Jordanians.
METHODS: Data were analyzed from a cross-sectional study that included a random sample of 1121 northern Jordanians aged 25 years and above. The metabolic syndrome was defined by ATP III criteria.
RESULTS: The age-adjusted prevalence of the metabolic syndrome was 36.3% (95% CI 33.6-39.0%) (28.7% among men and 40.9% among women). The prevalence increased significantly with age in men and women. The prevalence of the metabolic syndrome was significantly higher in women than in men in age groups of 40-49 and 60 years and above. Low HDL cholesterol was the most common abnormality in men (62.7%), and abdominal obesity was the most common abnormality in women (69.1%).
CONCLUSIONS: Prevalence of the metabolic syndrome in North Jordan is considerably higher than in developed countries and other Arab populations. An integrated approach is needed for the prevention and treatment of the metabolic syndrome.

Entities:  

Mesh:

Year:  2007        PMID: 17616350     DOI: 10.1016/j.jdiacomp.2005.11.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  24 in total

1.  Effects of a lifestyle modification trial among phenotypically obese metabolically normal and phenotypically obese metabolically abnormal adolescents in comparison with phenotypically normal metabolically obese adolescents.

Authors:  Roya Kelishadi; Mahin Hashemipour; Nizal Sarrafzadegan; Noushin Mohammadifard; Hasan Alikhasy; Maryam Beizaei; Firouzeh Sajjadi; Parinaz Poursafa; Zahra Amin; Shohreh Ghatreh-Samani; Noushin Khavarian; Zahra Dana Siadat
Journal:  Matern Child Nutr       Date:  2010-07-01       Impact factor: 3.092

Review 2.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

3.  Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study.

Authors:  Selçuk Altın; Tunç Ozan; Selçuk İlhan; Nevin İlhan; Rahmi Onur
Journal:  Turk J Urol       Date:  2015-09

4.  Metabolic syndrome between two ethnic minority groups (Circassians and Chechens) and the original inhabitants of Jordan.

Authors:  Rana Dajani; Yousef S Khader; Nancy Hakooz; Raja Fatahalla; Farouk Quadan
Journal:  Endocrine       Date:  2012-06-28       Impact factor: 3.633

5.  Gender and age-related differences in patients with the metabolic syndrome in a highly endogamous population.

Authors:  Abdulbari Bener; Abdul-Ghani Mohammad; Asia N Ismail; Mahmoud Zirie; Waleed K Abdullatef; Abdulla O A A Al-Hamaq
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

6.  Diabetes self-care management practices among insulin-taking patients.

Authors:  Besher Gharaibeh; Loai Issa Tawalbeh
Journal:  J Res Nurs       Date:  2018-07-23

7.  Decreasing prevalence of the full metabolic syndrome but a persistently high prevalence of dyslipidemia among adult Arabs.

Authors:  Nasser M Al-Daghri; Omar S Al-Attas; Majed S Alokail; Khalid M Alkharfy; Shaun Louie B Sabico; George P Chrousos
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

8.  Diet, genetics, and disease: a focus on the middle East and north Africa region.

Authors:  Akl C Fahed; Abdul-Karim M El-Hage-Sleiman; Theresa I Farhat; Georges M Nemer
Journal:  J Nutr Metab       Date:  2012-03-29

9.  Risk factors of non-communicable diseases and metabolic syndrome.

Authors:  N Esmailnasab; G Moradi; A Delaveri
Journal:  Iran J Public Health       Date:  2012-07-31       Impact factor: 1.429

10.  First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.

Authors:  Alireza Delavari; Mohammad Hossein Forouzanfar; Siamak Alikhani; Afsaneh Sharifian; Roya Kelishadi
Journal:  Diabetes Care       Date:  2009-03-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.